Service Line:+1-315-239-3085
Address:FL-4, Building A5, International Enterprise Community, Tianjin, China
Email:info@kmdbioscience.com
Catalog Number | YR1089 |
---|---|
Product Name | Anti-Human EGFR Recombinant Antibody(Cetuximab) |
Molecular Name | Cetuximab |
Alias | Anti-EGFR Recombinant Antibody, Research Grade Cetuximab |
CAS Number | 205923-56-4 |
Molecular Weight | 145.78 kDa |
Target | EGFR[Homo sapiens] |
Isotype | IgG1 Kappa |
Clonity | Monoclonal |
Source | CHO Cells |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Purity | >95% as determined by SDS-PAGE |
Applications | IF, IP, Neut, FuncS, ELISA, FCM |
Buffer | PBS, pH7.5 |
Background | Cetuximab is an epidermal growth factor receptor (EGFR) inhibitor medication used for the treatment of metastatic colorectal cancer and head and neck cancer. Cetuximab is a chimeric (mouse/human) monoclonal antibody given by intravenous infusion that is distributed under the trade name Erbitux in the U.S. and Canada by the drug company Eli Lilly and Co. |
Storage | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Note | This product is for research use only. |